KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Invested Capital (2016 - 2026)

Medtronic's Invested Capital history spans 14 years, with the latest figure at $49.4 billion for Q1 2026.

  • On a quarterly basis, Invested Capital fell 5.46% to $49.4 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $49.4 billion, a 5.46% decrease, with the full-year FY2025 number at $51.1 billion, down 0.74% from a year prior.
  • Invested Capital hit $49.4 billion in Q1 2026 for Medtronic, down from $50.3 billion in the prior quarter.
  • Over the last five years, Invested Capital for MDT hit a ceiling of $58.6 billion in Q3 2022 and a floor of $49.4 billion in Q1 2026.
  • Historically, Invested Capital has averaged $53.0 billion across 5 years, with a median of $52.2 billion in 2025.
  • Biggest five-year swings in Invested Capital: grew 13.36% in 2022 and later decreased 11.42% in 2023.
  • Tracing MDT's Invested Capital over 5 years: stood at $57.9 billion in 2022, then decreased by 8.52% to $53.0 billion in 2023, then dropped by 1.04% to $52.4 billion in 2024, then decreased by 4.12% to $50.3 billion in 2025, then fell by 1.77% to $49.4 billion in 2026.
  • Business Quant data shows Invested Capital for MDT at $49.4 billion in Q1 2026, $50.3 billion in Q4 2025, and $50.6 billion in Q3 2025.